Literature DB >> 27056720

Defining the roles for Vpr in HIV-1-associated neuropathogenesis.

Tony James1, Michael R Nonnemacher1, Brian Wigdahl1,2, Fred C Krebs3.   

Abstract

It is increasingly evident that the human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) has a unique role in neuropathogenesis. Its ability to induce G2/M arrest coupled with its capacity to increase viral gene transcription gives it a unique role in sustaining viral replication and aiding in the establishment and maintenance of a systemic infection. The requirement of Vpr for HIV-1 infection and replication in cells of monocytic origin (a key lineage of cells involved in HIV-1 neuroinvasion) suggests an important role in establishing and sustaining infection in the central nervous system (CNS). Contributions of Vpr to neuropathogenesis can be expanded further through (i) naturally occurring HIV-1 sequence variation that results in functionally divergent Vpr variants; (ii) the dual activities of Vpr as a intracellular protein delivered and expressed during HIV-1 infection and as an extracellular protein that can act on neighboring, uninfected cells; (iii) cell type-dependent consequences of Vpr expression and exposure, including cell cycle arrest, metabolic dysregulation, and cytotoxicity; and (iv) the effects of Vpr on exosome-based intercellular communication in the CNS. Revealing that the effects of this pleiotropic viral protein is an essential part of a greater understanding of HIV-1-associated pathogenesis and potential approaches to treating and preventing disease caused by HIV-1 infection.

Entities:  

Keywords:  Brain; Exosome; HIV-1; Neuropathogenesis; Vpr

Mesh:

Substances:

Year:  2016        PMID: 27056720      PMCID: PMC5144576          DOI: 10.1007/s13365-016-0436-5

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  84 in total

1.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 2.  Regulation of cell death: the calcium-apoptosis link.

Authors:  Sten Orrenius; Boris Zhivotovsky; Pierluigi Nicotera
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

3.  Protter: interactive protein feature visualization and integration with experimental proteomic data.

Authors:  Ulrich Omasits; Christian H Ahrens; Sebastian Müller; Bernd Wollscheid
Journal:  Bioinformatics       Date:  2013-10-24       Impact factor: 6.937

4.  Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression.

Authors:  P Roux; C Alfieri; M Hrimech; E A Cohen; J E Tanner
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  HIV-1 Vpr causes neuronal apoptosis and in vivo neurodegeneration.

Authors:  Gareth J Jones; Nicola L Barsby; Eric A Cohen; Janet Holden; Kim Harris; Peter Dickie; Jack Jhamandas; Christopher Power
Journal:  J Neurosci       Date:  2007-04-04       Impact factor: 6.167

6.  Defective brain development in mice lacking the Hif-1alpha gene in neural cells.

Authors:  Shuhei Tomita; Masaki Ueno; Masami Sakamoto; Yuki Kitahama; Masaaki Ueki; Nobuhiro Maekawa; Haruhiko Sakamoto; Max Gassmann; Ryoichiro Kageyama; Natsuo Ueda; Frank J Gonzalez; Yousuke Takahama
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients.

Authors:  Daniela Mologni; Paola Citterio; Barbara Menzaghi; Barbara Zanone Poma; Chiara Riva; Valentina Broggini; Alessandro Sinicco; Laura Milazzo; Fulvio Adorni; Stefano Rusconi; Massimo Galli; Agostino Riva
Journal:  AIDS       Date:  2006-02-28       Impact factor: 4.177

8.  HIV Nef is secreted in exosomes and triggers apoptosis in bystander CD4+ T cells.

Authors:  Metka Lenassi; Gerard Cagney; Maofu Liao; Tomaz Vaupotic; Koen Bartholomeeusen; Yifan Cheng; Nevan J Krogan; Ana Plemenitas; B Matija Peterlin
Journal:  Traffic       Date:  2010-01       Impact factor: 6.215

Review 9.  Extracellular vesicles as mediators of neuron-glia communication.

Authors:  Carsten Frühbeis; Dominik Fröhlich; Wen Ping Kuo; Eva-Maria Krämer-Albers
Journal:  Front Cell Neurosci       Date:  2013-10-30       Impact factor: 5.505

10.  Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.

Authors:  Francine C A Gérard; Ruifeng Yang; Bizhan Romani; Alexis Poisson; Jean-Philippe Belzile; Nicole Rougeau; Éric A Cohen
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

View more
  10 in total

Review 1.  Genetic variation and function of the HIV-1 Tat protein.

Authors:  Cassandra Spector; Anthony R Mele; Brian Wigdahl; Michael R Nonnemacher
Journal:  Med Microbiol Immunol       Date:  2019-03-05       Impact factor: 3.402

2.  HIV-1 Vpr protein impairs lysosome clearance causing SNCA/alpha-synuclein accumulation in neurons.

Authors:  Maryline Santerre; Sterling P Arjona; Charles Ns Allen; Shannon Callen; Shilpa Buch; Bassel E Sawaya
Journal:  Autophagy       Date:  2021-04-23       Impact factor: 16.016

Review 3.  The HIV-1 Vpr Protein: A Multifaceted Target for Therapeutic Intervention.

Authors:  María Eugenia González
Journal:  Int J Mol Sci       Date:  2017-01-10       Impact factor: 5.923

4.  Opinion: Inhibition of Blood-Brain Barrier Repair as a Mechanism in HIV-1 Disease.

Authors:  Monique E Maubert; Brian Wigdahl; Michael R Nonnemacher
Journal:  Front Neurosci       Date:  2017-04-26       Impact factor: 4.677

5.  Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study.

Authors:  Juraj Hlavatý; Zbyněk Tonar; Matthias Renner; Sylvia Panitz; Helga Petznek; Matthias Schweizer; Silke Schüle; Björn-Philipp Kloke; Rudolf Moldzio; Kirsti Witter
Journal:  Histochem Cell Biol       Date:  2017-04-10       Impact factor: 4.304

6.  Common gene-network signature of different neurological disorders and their potential implications to neuroAIDS.

Authors:  Vidya Sagar; S Pilakka-Kanthikeel; Paola C Martinez; V S R Atluri; M Nair
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

Review 7.  The role of exosomal transport of viral agents in persistent HIV pathogenesis.

Authors:  Benjamin J Patters; Santosh Kumar
Journal:  Retrovirology       Date:  2018-12-22       Impact factor: 4.602

Review 8.  How Viral and Intracellular Bacterial Pathogens Reprogram the Metabolism of Host Cells to Allow Their Intracellular Replication.

Authors:  Wolfgang Eisenreich; Thomas Rudel; Jürgen Heesemann; Werner Goebel
Journal:  Front Cell Infect Microbiol       Date:  2019-03-04       Impact factor: 5.293

9.  Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.

Authors:  Hager Mohamed; Ramona Clemen; Eric Freund; Jan-Wilm Lackmann; Kristian Wende; Jennifer Connors; Elias K Haddad; Will Dampier; Brian Wigdahl; Vandana Miller; Sander Bekeschus; Fred C Krebs
Journal:  PLoS One       Date:  2021-03-01       Impact factor: 3.240

Review 10.  Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders.

Authors:  Amila Omeragic; Olanre Kayode; Md Tozammel Hoque; Reina Bendayan
Journal:  Fluids Barriers CNS       Date:  2020-07-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.